ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB109

Use of the United States Renal Data System in Nontransplant Nephrology Research

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Sreenivasan, Anagha, University of Texas Austin, Austin, Texas, United States
  • Golestaneh, Ladan, Yale School of Medicine, New Haven, Connecticut, United States
  • Hemmige, Vagish, Montefiore Einstein Medical Center, New York, New York, United States
Background

The United States Renal Data System links data from Center for Medicare and Medicaid Service’s End-Stage Renal Disease program with Medicare insurance diagnosis codes, procedure codes, and medication reimbursement codes, and is freely available to researchers in the United States. The way these data are used by researchers, however, still needs to be explored.

Methods

We performed a PubMed search in June 2022 for the terms “United States Renal Data System” and “USRDS”. After selecting 100 published papers dating back to 2020, two members of the research team performed a structured analysis of each paper. Transplant-related papers and papers not conducting original patient-data research were excluded. Routine statistics were calculated in R.

Results

After excluding 13 papers without patient-level analyses and 28 transplant-related papers, a total of 59 papers met criteriaIn our data set, 32 studies (54%) used Institutional and 28 (47%) used Physician/Supplier files to identify ICD/CPT codes. 20 (34%) of studies used Part D files to determine medications. In addition, only 6 studies used crosswalk data (10%). Only 1 study (1.7%) used cost data.

Conclusion

The USRDS, in terms of improving dialysis outcomes, is underutilized, especially when it comes to cost data. More studies should be done to determine barriers to improved utilization of this resource.

CharacteristicN=59
Study was fundedYes47 (80%)
No12 (20%)
Language(s)* usedR13 (25%)
SAS36 (71%)
Stata14 (27%)
SPSS2 (3.9%)
Unknown8 (14%)
Code was sharedYes3 (5.1%)
No56 (94.9%)
File(s) used*Core59 (100%)
Institution32 (54%)
Physician28 (47%)
Hospital discharge31 (53%)
Transplant (UNOS)1 (1.7%)
Part D20 (34%)
Data extracted*Basic demographics59 (100%)
ICD-9 codes36 (61%)
ICD-10 codes19 (32%)
CPT codes23 (39%)
Medication20 (34%)
Transplant-related data8 (14%)
Costs1 (1.7%)
Residential16 (27%)
Crosswalks usedPhysician3 (5.1%)
Provider1 (1.7%)
Provider2 (3.4%)

*Percentages can add to over 100%

Digital Object Identifier (DOI)